Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Justin B. Klee

CEO at Amylyx Pharmaceuticals, Inc. (AMLX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.0M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 14SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 29,0253,614,495 held (−1%) $32.13 $933K -12.4%
Sep 14SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 1,4393,613,056 held (−0%) $33.16 $48K -15.1%
Mar 4SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 29,2823,334,616 held (−1%) $14.47 $424K +94.5%
Feb 4SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 15,5003,363,898 held (−0%) $14.69 $228K +91.6%
Jan 20SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 136,1933,378,546 held (−4%) $13.58 $1.8M +107.2%
Jan 20SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 1,9953,379,398 held (−0%) $13.89 $28K +102.6%
Jan 8SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 7,7153,317,586 held (−0%) $11.09 $86K +153.7%
Oct 2SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 29,7753,325,501 held (−1%) $14.37 $428K +95.8%
Oct 2SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 2003,325,301 held (−0%) $15.01 $3K +87.5%